Please see the mini-review below that proposes a package of precision medicine-guided therapies that has the prospect to drive clinical management decisions, based on both host immunity and M. tuberculosis strains genetics.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Achieving universal access to rapid tuberculosis diagnostics | 0 | 330 | May 26, 2023 | |
| Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges | 0 | 423 | July 30, 2019 | |
| Culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis | 0 | 23 | October 31, 2024 | |
| Call for submission to Frontiers in Microbiology | 0 | 274 | July 8, 2021 | |
| Tuberculosis diagnosis and treatment under uncertainty | 0 | 428 | November 28, 2019 |